Loading
Only a handful of insider records exist for Algernon Pharmaceuticals Inc., the last one from 2 August 2024, too few to describe a trend. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
1 of 1 declaration
Algernon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing new treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.